Radiopharmaceuticals in Nuclear Medicine Market is Anticipated to Witness High Growth Owing to Rising Incidence of Chronic Diseases

The global radiopharmaceuticals in nuclear medicine market is estimated to be valued at USD 7.72 Bn in 2025 and is expected to exhibit a CAGR of 8.7% over the forecast period 2025 to 2032.

Radiopharmaceuticals play a pivotal role in nuclear medicine and are used for both diagnostic and therapeutic procedures. These are radioactive compounds administered to patients for diagnosis and therapeutic purposes such as cancer treatment.

Get more insights on, Radiopharmaceuticals in Nuclear Medicine Market- https://www.patreon.com/po...

#CoherentMarketInsights #RadiopharmaceuticalsinNuclearMedicineMarket #RadiopharmaceuticalsinNuclearMedicine #DiagnosticNuclearMedicine
#RadiopharmaceuticalsinNuclearMedicineMarketInsights